Breaking down U.S. strategy to end the HIV epidemic by 2030
Céline Gounder, KFF Health News' editor-at-large for public health, explained on "CBS Mornings" why many at-risk Americans do not know about medication to prevent HIV infection through sexual contact or do not have access to it.
Only one-third of people who could benefit from the medication, known as preexposure prophylaxis or PrEP, are prescribed it, according to the Centers for Disease Control and Prevention.
|
 This article was reprinted from khn.org, a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF - the independent source for health policy research, polling, and journalism.
|
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus